Is Parnax Lab overvalued or undervalued?

As of 17 October 2025, Parnax Lab's valuation grade has moved from attractive to fair, indicating a shift in market perception. The company appears to be fairly valued based on its current metrics, with a PE ratio of 13.55, an EV to EBITDA of 8.33, and a ROE of 13.86%.
When compared to peers, Parnax Lab's valuation stands out against Elitecon International, which is deemed very expensive with a PE ratio of 358.65, and PTC India, which is very attractive with a PE of 7.81. This suggests that while Parnax Lab is not undervalued, it is also not overvalued relative to its peers. The recent stock performance has lagged behind the Sensex, with a year-to-date return of -24.08% compared to the Sensex's 7.44%, reinforcing the notion that the stock may be fairly valued in the current market environment.